| scholarly article | Q13442814 |
| P356 | DOI | 10.1191/096120398678919868 |
| P8608 | Fatcat ID | release_gczn72v6srezth6z36p7asqsnq |
| P698 | PubMed publication ID | 9541097 |
| P2093 | author name string | D Leys | |
| B Devulder | |||
| E Hachulla | |||
| J P Pruvo | |||
| P Y Hatron | |||
| V Queyrel | |||
| J Arvieux | |||
| C Caron | |||
| U Michon-Pasturel | |||
| E Masy | |||
| F Brevet-Coupé | |||
| P2860 | cites work | The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 |
| Antiphospholipid antibody syndrome: immunologic and clinical aspects | Q33400810 | ||
| Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases | Q33408807 | ||
| Neurologic manifestations associated with antiphospholipid antibodies. Or what remains of neurolupus? | Q33489415 | ||
| Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies | Q33555845 | ||
| Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus | Q33562233 | ||
| Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy | Q33584052 | ||
| Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome | Q41238775 | ||
| Magnetic resonance imaging in systemic lupus erythematosus patients without a history of neuropsychiatric lupus erythematosus | Q43550890 | ||
| Magnetic resonance imaging of periventricular hyperintensity in a Veterans Administration hospital population | Q45336937 | ||
| Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus | Q46909297 | ||
| Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning | Q48115666 | ||
| Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. | Q48144813 | ||
| Incidental subcortical lesions identified on magnetic resonance imaging in the elderly. I. Correlation with age and cerebrovascular risk factors | Q48278329 | ||
| MRI periventricular lesions in adults | Q48326647 | ||
| A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging | Q48360275 | ||
| Anticardiolipin antibodies and the risk for ischemic stroke and venous thrombosis | Q48394757 | ||
| Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals | Q48747600 | ||
| Magnetic resonance imaging of central nervous system lesions in patients with lupus erythematosus. Correlation with clinical remission and antineurofilament and anticardiolipin antibody titers | Q48752879 | ||
| Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus | Q48820031 | ||
| Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings | Q49226626 | ||
| Periventricular and white matter magnetic resonance imaging hyperintensities do not differ between Alzheimer's disease and normal aging. | Q52058009 | ||
| Magnetic Resonance Signal Abnormalities in Asymptomatic Individuals: Their Incidence and Functional Correlates | Q57588832 | ||
| P433 | issue | 2 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 124-131 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Lupus | Q6704846 |
| P1476 | title | Cerebral magnetic resonance imaging in patients with or without antiphospholipid antibodies | |
| P478 | volume | 7 |
| Q28192380 | Antiphospholipid antibodies in young adults with stroke |
| Q60907847 | Are serum autoantibodies associated with brain changes in systemic lupus erythematosus? MRI data from the Leiden NP-SLE cohort |
| Q35673044 | Autoantibodies Affect Brain Density Reduction in Nonneuropsychiatric Systemic Lupus Erythematosus Patients. |
| Q42442000 | Brain MR findings in patients with systemic lupus erythematosus with and without antiphospholipid antibody syndrome |
| Q35455167 | Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study |
| Q49562027 | Clinical Factors Associated with Brain Volume Reduction in Systemic Lupus Erythematosus Patients without Major Neuropsychiatric Manifestations |
| Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
| Q48618855 | Comparison of neuropsychological impairment and vocational outcomes in systemic lupus erythematosus and multiple sclerosis patients |
| Q33547420 | Cortical thickness and subcortical gray matter reductions in neuropsychiatric systemic lupus erythematosus |
| Q74385636 | Diffusion-weighted echo-planar MR imaging of CNS involvement in systemic lupus erythematosus |
| Q47380662 | Factors associated with increased white matter hyperintense lesion (WMHI) load in patients with systemic lupus erythematosus (SLE). |
| Q31101744 | Hughes syndrome and epilepsy: when to test for antiphospholipid antibodies? |
| Q44698496 | In vivo proton magnetic resonance spectroscopy (MRS) and single photon emission computerized tomography (SPECT) in systemic lupus erythematosus (SLE). |
| Q48504500 | MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis |
| Q33753228 | Neuroimaging in neuropsychiatric systemic lupus erythematosus |
| Q34317758 | Neuroimaging techniques in the diagnostic work-up of patients with the antiphospholipid syndrome. |
| Q80335294 | Neurologic manifestations of the antiphospholipid syndrome |
| Q33339985 | Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis |
| Q36270159 | Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital |
| Q74485994 | The differential diagnosis of multiple sclerosis |
| Q77467515 | [Neurological manifestations of antiphospholipid syndrome] |
Search more.